CASE DISCUSSION
Thyroid Nodules in Children: When to Worry?
Presented India by Dr. Rahul ReddyViews
5,187
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Thyroid nodules in children are less common than in adults but carry a higher risk of malignancy. Most nodules are benign, often linked to iodine deficiency, inflammation, or cysts. However, warning signs that warrant concern include rapid growth, firmness, hoarseness, difficulty swallowing, or...
Case Summary
- Thyroid nodules in children, while rare, present a higher risk of malignancy compared to adults, making accurate identification crucial. Guidelines from the American Thyroid Association (ATA) and the European Thyroid Association (ETA) provide frameworks for evaluation and management, emphasizing the importance of personal and family history to identify potential hereditary syndromes associated with increased thyroid cancer risk.
Speaker Profile
Dr. Rahul Reddy
Consultant - Pediatric Endocrinology at Ankura Hospitals, HyderabadDr. C. Rahul Reddy is a dynamic Pediatric Endocrinologist with over a decade of experience in his field. He specializes in managing growth disorders, pediatric and adolescent diabetes, thyroid conditions, and other endocrine issues in children. Dr. Rahul completed his MBBS at Osmania Medical College, Hyderabad, followed by a DCH and MD from Christian Medical College (CMC), Vellore. He further honed his expertise during a fellowship in Pediatric Endocrinology at the National University Hospital, Singapore. Currently serving as Consultant Pediatric Endocrinologist at Ankura Hospital for Women and Children, Dr Rahul is dedicated to improving children’s health, with a particular interest in growth problems, type 1 diabetes, and thyroid disorders. Throughout his career, he has contributed significantly to his field, presenting at national and international conferences and publishing research on pediatric endocrinology. His work includes treating rare and complex cases, such as monogenic diabetes and congenital adrenal hyperplasia.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.